Copenhagen, 06 Nov 2002

Meeting of the COST JAF Group will take place in the following three parts:

Part I:

10h00: Biomaterials
Chair: Prof. Luc Balant

1. Introduction and adoption of the agenda

2. Adoption of the minutes of the previous meeting

3. "Biomaterials in the general, vascular and heart surgery in the limelight of long-term clinical follow up " (Ferenc Jacab)

4. "Interdisciplinary biomat centres: difficulties and synergies between four different faculties, including the Faculty of Medicine, and the cooperation with industry" (Hartwig H?cker)

5. Ethical issues in "biomaterials" (Knut W. Ruyter)

ÍøÆØÃÅ

6. News from the relevant COST Technical Committees

7. Proposals for new COST Actions related to biomaterials

ÍøÆØÃÅ

8. Strategies for biomaterials research in the Framework Programmes of the European Commission (Gianpietro van de Goor)

9. General discussion in the light of the CSO mandate (doc. COST 312/2/01 REV 2)

10. Any other items with regard to biomaterials

Part II
14h00: SIG
Chair: Prof. John Bartzis, Vice-Chair, CSO

11. Outcome of the Chemistry Workshop (presentation by the TC Chemistry Chairman)

12. Outcome of the NANOSTAG brainstorm meeting (presentation by the TC NANOSTAG Chairman)

ÍøÆØÃÅ

13. International Cooperation (Proposal from the Greek delegation, doc. COST 240/02 Annex 2)

14. Issues related to the CSO - TC Chairs meeting on 2 December

15. TC Evaluation/Restructuring (doc. COST 267/02)

16. Any other items of strategic interest

Part III:

The meeting will continue on Tuesday, 19 November, at 10h00 09h00

ÍøÆØÃÅ

Chair: Eva M. KLAPER, Vice-Chair, CSO

17. COST Action Statistics

18. Budget: status and budget allocation 2003 and indicative planning up to 2006 (duration of FP6)

19. Creation of 5th COST Fund: volume ¨C exchange of opinions

20. Voting rules: exchange of opinions

21. Reimbursement of TC delegates: preparation of general decision and practicalities

22. Any other business

Danish Presidency Website

ÍøÆØÃÅ